Mark T. Gladwin

69.5k citations
533 papers · 44.8k · 21 hit papers · h-index 107

Impact in

  • Genetics top 0.01%
    • Hemoglobinopathies and Related Disorders
  • Hematology top 0.02%
    • Iron Metabolism and Disorders

Papers in

    • Hemoglobinopathies and Related Disorders 218
    • Nitric Oxide and Endothelin Effects 125
    • Erythrocyte Function and Pathophysiology 38

Mark T. Gladwin

511 papers receiving 43.9k citations

Mark T. Gladwin's Hit Papers

Research Priorities for Heart Failure With Preserved Ejection Fraction 2020 · 286 citations
2860+7+14Years since publication50010001.5k2.0k

Peers

Mark T. Gladwin
Comparison fields: 5 of 188
  • Genetics 13.6k
  • Hematology 7.9k
  • Physiology 14.1k
  • Biochemistry 2.9k
  • Endocrine and Autonomic Systems 2.5k
Replace Masayuki Yamamoto with:
Masayuki Yamamoto Japan
Stefanie Dimmeler Germany
Andreas M. Zeiher Germany
Alan N. Schechter United States
Kenneth Walsh United States
Russell Ross United States
Ernest Beutler United States
Asrar B. Malik United States
Thomas F. Lüscher Switzerland
Toren Finkel United States
Mark T. Gladwin relative to Masayuki Yamamoto Japan Masayuki Yamamoto's profile →
Citations per field
00.5×4.3×
Masayuki Yamamoto · 1×
Citations per year

Countries citing papers authored by Mark T. Gladwin

Since Specialization
Citations

This map shows the geographic impact of Mark T. Gladwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark T. Gladwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark T. Gladwin more than expected).

Fields of papers citing papers by Mark T. Gladwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark T. Gladwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark T. Gladwin. The network helps show where Mark T. Gladwin may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark T. Gladwin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark T. Gladwin Line = papers co-authored together Mark T. Gladwin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 533 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics
Hit paper breakdown →
20082111
2
Sickle-cell disease
Hit paper breakdown →
20101709
3
Updated Clinical Classification of Pulmonary Hypertension
Hit paper breakdown →
20091513
4
Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation
Hit paper breakdown →
20031424
5
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
Hit paper breakdown →
20051193
6
Right Ventricular Function and Failure
Hit paper breakdown →
2006934
7
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Hit paper breakdown →
2004925
8
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Hit paper breakdown →
2002919
9
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Hit paper breakdown →
2002886
10
Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes
Hit paper breakdown →
2006594
11
Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver
Hit paper breakdown →
2005537
12
Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy
Hit paper breakdown →
2016527
13
Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease
Hit paper breakdown →
2005518
14 2007486
15 2005474
16
Strategies to increase nitric oxide signalling in cardiovascular disease
Hit paper breakdown →
2015469
17
Intravascular hemolysis and the pathophysiology of sickle cell disease
Hit paper breakdown →
2017469
18
Nitric Oxide Scavenging by Red Blood Cell Microparticles and Cell-Free Hemoglobin as a Mechanism for the Red Cell Storage Lesion
Hit paper breakdown →
2011455
19 2007454
20
Pathophysiology of Sickle Cell Disease
Hit paper breakdown →
2018450

About Mark T. Gladwin

Mark T. Gladwin is a scholar working on Genetics, Physiology, Hematology, Cell Biology and Molecular Biology, having authored 533 papers that have together received 44.8k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (218 papers), Nitric Oxide and Endothelin Effects (125 papers), Hemoglobin structure and function (109 papers), Iron Metabolism and Disorders (97 papers), Pulmonary Hypertension Research and Treatments (66 papers), Neuroscience of respiration and sleep (52 papers), Heme Oxygenase-1 and Carbon Monoxide (46 papers) and Erythrocyte Function and Pathophysiology (38 papers). The work is most often cited by research in Genetics (13.6k citations), Hematology (7.9k citations), Physiology (14.1k citations), Biochemistry (2.9k citations) and Endocrine and Autonomic Systems (2.5k citations). Mark T. Gladwin has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Alan N. Schechter, Daniel B. Kim‐Shapiro, Gregory J. Kato, Jon O. Lundberg, Sruti Shiva, Eddie Weitzberg, Neil Hogg, Thomas N. Williams, David C. Rees and Xunde Wang. Their work appears in journals such as Blood, Free Radical Biology and Medicine, British Journal of Haematology, Circulation and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact